Somerset Pharma intros 4 generics

Somerset is expanding its generic ophthalmics portfolio.

1/28/2025

Someset Pharma is introducing four sterile ophthalmic products as part of its growing ophthalmics portfolio.

The company is launching bepotastine besilate 1.5%, which is the generic of Bepreve, an antihistamine eye drop used to treat itching caused by allergic conjunctivitis.

The second new generic is proparacaine hydrochloride 0.5%, which is a generic of Alcaine, a topical local anesthetic for short duration corneal and conjunctival procedures.

Travoprost 0.004%, is the third new generic from Somerset Pharma. The medication is the generic of Travatan Z, which is a prostaglandin analog used to relieve ocular hypertension and treat glaucoma.

The fourth new generic from the company is moxifloxacin 0.5%, which is a generic of Vigamox.

Vigamox is an antibiotic indicated for the treatment of bacterial conjunctivitis.

“We are grateful for the opportunity to supply quality products to our healthcare partners and contribute to their mission of providing exceptional patient care. We also aim to make the supply chain for these products more resilient, making them easily accessible to our healthcare partners and the patients under their care,” said Arun Menon, chief commercial officer at Somerset Pharma.

"The addition of these four products to Somerset’s growing portfolio of ophthalmic products further strengthens our commitment to providing high quality medication at affordable prices," the company said.